Loading…
Exploring the Complexity of Death-Censored Kidney Allograft Failure
Few studies have thoroughly investigated the causes of kidney graft loss (GL), despite its importance. A novel approach assigns each persistent and relevant decline in renal function over the lifetime of a renal allograft to a standardized category, hypothesizing that singular or multiple events fin...
Saved in:
Published in: | Journal of the American Society of Nephrology 2021-06, Vol.32 (6), p.1513-1526 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c435t-4dfb3f0cb88155a6e45634b4b52a68aabbdefc4e814e6b81443545a88d616d053 |
---|---|
cites | cdi_FETCH-LOGICAL-c435t-4dfb3f0cb88155a6e45634b4b52a68aabbdefc4e814e6b81443545a88d616d053 |
container_end_page | 1526 |
container_issue | 6 |
container_start_page | 1513 |
container_title | Journal of the American Society of Nephrology |
container_volume | 32 |
creator | Mayrdorfer, Manuel Liefeldt, Lutz Wu, Kaiyin Rudolph, Birgit Zhang, Qiang Friedersdorff, Frank Lachmann, Nils Schmidt, Danilo Osmanodja, Bilgin Naik, Marcel G Duettmann, Wiebke Halleck, Fabian Merkel, Marina Schrezenmeier, Eva Waiser, Johannes Duerr, Michael Budde, Klemens |
description | Few studies have thoroughly investigated the causes of kidney graft loss (GL), despite its importance.
A novel approach assigns each persistent and relevant decline in renal function over the lifetime of a renal allograft to a standardized category, hypothesizing that singular or multiple events finally lead to GL. An adjudication committee of three physicians retrospectively evaluated indication biopsies, laboratory testing, and medical history of all 303 GLs among all 1642 recipients of transplants between January 1, 1997 and December 31, 2017 at a large university hospital to assign primary and/or secondary causes of GL.
In 51.2% of the patients, more than one cause contributed to GL. The most frequent primary or secondary causes leading to graft failure were intercurrent medical events in 36.3% of graft failures followed by T cell-mediated rejection (TCMR) in 34% and antibody-mediated rejection (ABMR) in 30.7%. In 77.9%, a primary cause could be attributed to GL, of which ABMR was most frequent (21.5%). Many causes for GL were identified, and predominant causes for GL varied over time.
GL is often multifactorial and more complex than previously thought. |
doi_str_mv | 10.1681/ASN.2020081215 |
format | article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8259637</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>33883251</sourcerecordid><originalsourceid>FETCH-LOGICAL-c435t-4dfb3f0cb88155a6e45634b4b52a68aabbdefc4e814e6b81443545a88d616d053</originalsourceid><addsrcrecordid>eNpVkE1PwzAMhiMEYmNw5Yj6BzqS5qPhgjSVDRATHIBzlDTOFtQ1VdpN27-naDDgYluyn9fSg9AlwWMiJLmevD6PM5xhLElG-BEaEk5pShnHx_2MmUiFyOkAnbXtB8aEZ3l-igaUSkkzToaomG6bKkRfL5JuCUkRVk0FW9_tkuCSO9DdMi2gbkMEmzx5W8MumVRVWETtumSmfbWOcI5OnK5auPjuI_Q-m74VD-n85f6xmMzTklHepcw6Qx0ujZSEcy2AcUGZYYZnWkitjbHgSgaSMBCmrz3FuJbSCiIs5nSEbve5zdqswJZQd1FXqol-peNOBe3V_03tl2oRNkpm_EbQvA8Y7wPKGNo2gjuwBKsvnarXqX519sDV34-H8x9_9BMVPXFc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Exploring the Complexity of Death-Censored Kidney Allograft Failure</title><source>PubMed Central (Open Access)</source><source>Elektronische Zeitschriftenbibliothek</source><creator>Mayrdorfer, Manuel ; Liefeldt, Lutz ; Wu, Kaiyin ; Rudolph, Birgit ; Zhang, Qiang ; Friedersdorff, Frank ; Lachmann, Nils ; Schmidt, Danilo ; Osmanodja, Bilgin ; Naik, Marcel G ; Duettmann, Wiebke ; Halleck, Fabian ; Merkel, Marina ; Schrezenmeier, Eva ; Waiser, Johannes ; Duerr, Michael ; Budde, Klemens</creator><creatorcontrib>Mayrdorfer, Manuel ; Liefeldt, Lutz ; Wu, Kaiyin ; Rudolph, Birgit ; Zhang, Qiang ; Friedersdorff, Frank ; Lachmann, Nils ; Schmidt, Danilo ; Osmanodja, Bilgin ; Naik, Marcel G ; Duettmann, Wiebke ; Halleck, Fabian ; Merkel, Marina ; Schrezenmeier, Eva ; Waiser, Johannes ; Duerr, Michael ; Budde, Klemens</creatorcontrib><description>Few studies have thoroughly investigated the causes of kidney graft loss (GL), despite its importance.
A novel approach assigns each persistent and relevant decline in renal function over the lifetime of a renal allograft to a standardized category, hypothesizing that singular or multiple events finally lead to GL. An adjudication committee of three physicians retrospectively evaluated indication biopsies, laboratory testing, and medical history of all 303 GLs among all 1642 recipients of transplants between January 1, 1997 and December 31, 2017 at a large university hospital to assign primary and/or secondary causes of GL.
In 51.2% of the patients, more than one cause contributed to GL. The most frequent primary or secondary causes leading to graft failure were intercurrent medical events in 36.3% of graft failures followed by T cell-mediated rejection (TCMR) in 34% and antibody-mediated rejection (ABMR) in 30.7%. In 77.9%, a primary cause could be attributed to GL, of which ABMR was most frequent (21.5%). Many causes for GL were identified, and predominant causes for GL varied over time.
GL is often multifactorial and more complex than previously thought.</description><identifier>ISSN: 1046-6673</identifier><identifier>EISSN: 1533-3450</identifier><identifier>DOI: 10.1681/ASN.2020081215</identifier><identifier>PMID: 33883251</identifier><language>eng</language><publisher>United States: American Society of Nephrology</publisher><subject>Adult ; Aged ; Allografts - pathology ; Allografts - physiopathology ; Allografts - statistics & numerical data ; Calcineurin Inhibitors - adverse effects ; Cardio-Renal Syndrome - complications ; Clinical Research ; Databases, Factual ; Death ; Female ; Graft Rejection - immunology ; Graft Rejection - prevention & control ; Graft Survival ; Humans ; Immunity, Cellular ; Immunity, Humoral ; Immunosuppressive Agents - therapeutic use ; Kidney Failure, Chronic - surgery ; Kidney Transplantation - standards ; Kidney Transplantation - statistics & numerical data ; Male ; Medication Adherence - statistics & numerical data ; Middle Aged ; Polyomavirus Infections - complications ; Recurrence ; Retrospective Studies ; Survival Rate ; T-Lymphocytes ; Thrombosis - complications ; Time Factors ; Tumor Virus Infections - complications</subject><ispartof>Journal of the American Society of Nephrology, 2021-06, Vol.32 (6), p.1513-1526</ispartof><rights>Copyright © 2021 by the American Society of Nephrology.</rights><rights>Copyright © 2021 by the American Society of Nephrology 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c435t-4dfb3f0cb88155a6e45634b4b52a68aabbdefc4e814e6b81443545a88d616d053</citedby><cites>FETCH-LOGICAL-c435t-4dfb3f0cb88155a6e45634b4b52a68aabbdefc4e814e6b81443545a88d616d053</cites><orcidid>0000-0002-6063-2806 ; 0000-0001-5236-2749 ; 0000-0003-3872-3477 ; 0000-0002-7929-5942 ; 0000-0002-6988-8269</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259637/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259637/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33883251$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mayrdorfer, Manuel</creatorcontrib><creatorcontrib>Liefeldt, Lutz</creatorcontrib><creatorcontrib>Wu, Kaiyin</creatorcontrib><creatorcontrib>Rudolph, Birgit</creatorcontrib><creatorcontrib>Zhang, Qiang</creatorcontrib><creatorcontrib>Friedersdorff, Frank</creatorcontrib><creatorcontrib>Lachmann, Nils</creatorcontrib><creatorcontrib>Schmidt, Danilo</creatorcontrib><creatorcontrib>Osmanodja, Bilgin</creatorcontrib><creatorcontrib>Naik, Marcel G</creatorcontrib><creatorcontrib>Duettmann, Wiebke</creatorcontrib><creatorcontrib>Halleck, Fabian</creatorcontrib><creatorcontrib>Merkel, Marina</creatorcontrib><creatorcontrib>Schrezenmeier, Eva</creatorcontrib><creatorcontrib>Waiser, Johannes</creatorcontrib><creatorcontrib>Duerr, Michael</creatorcontrib><creatorcontrib>Budde, Klemens</creatorcontrib><title>Exploring the Complexity of Death-Censored Kidney Allograft Failure</title><title>Journal of the American Society of Nephrology</title><addtitle>J Am Soc Nephrol</addtitle><description>Few studies have thoroughly investigated the causes of kidney graft loss (GL), despite its importance.
A novel approach assigns each persistent and relevant decline in renal function over the lifetime of a renal allograft to a standardized category, hypothesizing that singular or multiple events finally lead to GL. An adjudication committee of three physicians retrospectively evaluated indication biopsies, laboratory testing, and medical history of all 303 GLs among all 1642 recipients of transplants between January 1, 1997 and December 31, 2017 at a large university hospital to assign primary and/or secondary causes of GL.
In 51.2% of the patients, more than one cause contributed to GL. The most frequent primary or secondary causes leading to graft failure were intercurrent medical events in 36.3% of graft failures followed by T cell-mediated rejection (TCMR) in 34% and antibody-mediated rejection (ABMR) in 30.7%. In 77.9%, a primary cause could be attributed to GL, of which ABMR was most frequent (21.5%). Many causes for GL were identified, and predominant causes for GL varied over time.
GL is often multifactorial and more complex than previously thought.</description><subject>Adult</subject><subject>Aged</subject><subject>Allografts - pathology</subject><subject>Allografts - physiopathology</subject><subject>Allografts - statistics & numerical data</subject><subject>Calcineurin Inhibitors - adverse effects</subject><subject>Cardio-Renal Syndrome - complications</subject><subject>Clinical Research</subject><subject>Databases, Factual</subject><subject>Death</subject><subject>Female</subject><subject>Graft Rejection - immunology</subject><subject>Graft Rejection - prevention & control</subject><subject>Graft Survival</subject><subject>Humans</subject><subject>Immunity, Cellular</subject><subject>Immunity, Humoral</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Kidney Failure, Chronic - surgery</subject><subject>Kidney Transplantation - standards</subject><subject>Kidney Transplantation - statistics & numerical data</subject><subject>Male</subject><subject>Medication Adherence - statistics & numerical data</subject><subject>Middle Aged</subject><subject>Polyomavirus Infections - complications</subject><subject>Recurrence</subject><subject>Retrospective Studies</subject><subject>Survival Rate</subject><subject>T-Lymphocytes</subject><subject>Thrombosis - complications</subject><subject>Time Factors</subject><subject>Tumor Virus Infections - complications</subject><issn>1046-6673</issn><issn>1533-3450</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNpVkE1PwzAMhiMEYmNw5Yj6BzqS5qPhgjSVDRATHIBzlDTOFtQ1VdpN27-naDDgYluyn9fSg9AlwWMiJLmevD6PM5xhLElG-BEaEk5pShnHx_2MmUiFyOkAnbXtB8aEZ3l-igaUSkkzToaomG6bKkRfL5JuCUkRVk0FW9_tkuCSO9DdMi2gbkMEmzx5W8MumVRVWETtumSmfbWOcI5OnK5auPjuI_Q-m74VD-n85f6xmMzTklHepcw6Qx0ujZSEcy2AcUGZYYZnWkitjbHgSgaSMBCmrz3FuJbSCiIs5nSEbve5zdqswJZQd1FXqol-peNOBe3V_03tl2oRNkpm_EbQvA8Y7wPKGNo2gjuwBKsvnarXqX519sDV34-H8x9_9BMVPXFc</recordid><startdate>20210601</startdate><enddate>20210601</enddate><creator>Mayrdorfer, Manuel</creator><creator>Liefeldt, Lutz</creator><creator>Wu, Kaiyin</creator><creator>Rudolph, Birgit</creator><creator>Zhang, Qiang</creator><creator>Friedersdorff, Frank</creator><creator>Lachmann, Nils</creator><creator>Schmidt, Danilo</creator><creator>Osmanodja, Bilgin</creator><creator>Naik, Marcel G</creator><creator>Duettmann, Wiebke</creator><creator>Halleck, Fabian</creator><creator>Merkel, Marina</creator><creator>Schrezenmeier, Eva</creator><creator>Waiser, Johannes</creator><creator>Duerr, Michael</creator><creator>Budde, Klemens</creator><general>American Society of Nephrology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-6063-2806</orcidid><orcidid>https://orcid.org/0000-0001-5236-2749</orcidid><orcidid>https://orcid.org/0000-0003-3872-3477</orcidid><orcidid>https://orcid.org/0000-0002-7929-5942</orcidid><orcidid>https://orcid.org/0000-0002-6988-8269</orcidid></search><sort><creationdate>20210601</creationdate><title>Exploring the Complexity of Death-Censored Kidney Allograft Failure</title><author>Mayrdorfer, Manuel ; Liefeldt, Lutz ; Wu, Kaiyin ; Rudolph, Birgit ; Zhang, Qiang ; Friedersdorff, Frank ; Lachmann, Nils ; Schmidt, Danilo ; Osmanodja, Bilgin ; Naik, Marcel G ; Duettmann, Wiebke ; Halleck, Fabian ; Merkel, Marina ; Schrezenmeier, Eva ; Waiser, Johannes ; Duerr, Michael ; Budde, Klemens</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c435t-4dfb3f0cb88155a6e45634b4b52a68aabbdefc4e814e6b81443545a88d616d053</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Allografts - pathology</topic><topic>Allografts - physiopathology</topic><topic>Allografts - statistics & numerical data</topic><topic>Calcineurin Inhibitors - adverse effects</topic><topic>Cardio-Renal Syndrome - complications</topic><topic>Clinical Research</topic><topic>Databases, Factual</topic><topic>Death</topic><topic>Female</topic><topic>Graft Rejection - immunology</topic><topic>Graft Rejection - prevention & control</topic><topic>Graft Survival</topic><topic>Humans</topic><topic>Immunity, Cellular</topic><topic>Immunity, Humoral</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Kidney Failure, Chronic - surgery</topic><topic>Kidney Transplantation - standards</topic><topic>Kidney Transplantation - statistics & numerical data</topic><topic>Male</topic><topic>Medication Adherence - statistics & numerical data</topic><topic>Middle Aged</topic><topic>Polyomavirus Infections - complications</topic><topic>Recurrence</topic><topic>Retrospective Studies</topic><topic>Survival Rate</topic><topic>T-Lymphocytes</topic><topic>Thrombosis - complications</topic><topic>Time Factors</topic><topic>Tumor Virus Infections - complications</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mayrdorfer, Manuel</creatorcontrib><creatorcontrib>Liefeldt, Lutz</creatorcontrib><creatorcontrib>Wu, Kaiyin</creatorcontrib><creatorcontrib>Rudolph, Birgit</creatorcontrib><creatorcontrib>Zhang, Qiang</creatorcontrib><creatorcontrib>Friedersdorff, Frank</creatorcontrib><creatorcontrib>Lachmann, Nils</creatorcontrib><creatorcontrib>Schmidt, Danilo</creatorcontrib><creatorcontrib>Osmanodja, Bilgin</creatorcontrib><creatorcontrib>Naik, Marcel G</creatorcontrib><creatorcontrib>Duettmann, Wiebke</creatorcontrib><creatorcontrib>Halleck, Fabian</creatorcontrib><creatorcontrib>Merkel, Marina</creatorcontrib><creatorcontrib>Schrezenmeier, Eva</creatorcontrib><creatorcontrib>Waiser, Johannes</creatorcontrib><creatorcontrib>Duerr, Michael</creatorcontrib><creatorcontrib>Budde, Klemens</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of the American Society of Nephrology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mayrdorfer, Manuel</au><au>Liefeldt, Lutz</au><au>Wu, Kaiyin</au><au>Rudolph, Birgit</au><au>Zhang, Qiang</au><au>Friedersdorff, Frank</au><au>Lachmann, Nils</au><au>Schmidt, Danilo</au><au>Osmanodja, Bilgin</au><au>Naik, Marcel G</au><au>Duettmann, Wiebke</au><au>Halleck, Fabian</au><au>Merkel, Marina</au><au>Schrezenmeier, Eva</au><au>Waiser, Johannes</au><au>Duerr, Michael</au><au>Budde, Klemens</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Exploring the Complexity of Death-Censored Kidney Allograft Failure</atitle><jtitle>Journal of the American Society of Nephrology</jtitle><addtitle>J Am Soc Nephrol</addtitle><date>2021-06-01</date><risdate>2021</risdate><volume>32</volume><issue>6</issue><spage>1513</spage><epage>1526</epage><pages>1513-1526</pages><issn>1046-6673</issn><eissn>1533-3450</eissn><abstract>Few studies have thoroughly investigated the causes of kidney graft loss (GL), despite its importance.
A novel approach assigns each persistent and relevant decline in renal function over the lifetime of a renal allograft to a standardized category, hypothesizing that singular or multiple events finally lead to GL. An adjudication committee of three physicians retrospectively evaluated indication biopsies, laboratory testing, and medical history of all 303 GLs among all 1642 recipients of transplants between January 1, 1997 and December 31, 2017 at a large university hospital to assign primary and/or secondary causes of GL.
In 51.2% of the patients, more than one cause contributed to GL. The most frequent primary or secondary causes leading to graft failure were intercurrent medical events in 36.3% of graft failures followed by T cell-mediated rejection (TCMR) in 34% and antibody-mediated rejection (ABMR) in 30.7%. In 77.9%, a primary cause could be attributed to GL, of which ABMR was most frequent (21.5%). Many causes for GL were identified, and predominant causes for GL varied over time.
GL is often multifactorial and more complex than previously thought.</abstract><cop>United States</cop><pub>American Society of Nephrology</pub><pmid>33883251</pmid><doi>10.1681/ASN.2020081215</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0002-6063-2806</orcidid><orcidid>https://orcid.org/0000-0001-5236-2749</orcidid><orcidid>https://orcid.org/0000-0003-3872-3477</orcidid><orcidid>https://orcid.org/0000-0002-7929-5942</orcidid><orcidid>https://orcid.org/0000-0002-6988-8269</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1046-6673 |
ispartof | Journal of the American Society of Nephrology, 2021-06, Vol.32 (6), p.1513-1526 |
issn | 1046-6673 1533-3450 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8259637 |
source | PubMed Central (Open Access); Elektronische Zeitschriftenbibliothek |
subjects | Adult Aged Allografts - pathology Allografts - physiopathology Allografts - statistics & numerical data Calcineurin Inhibitors - adverse effects Cardio-Renal Syndrome - complications Clinical Research Databases, Factual Death Female Graft Rejection - immunology Graft Rejection - prevention & control Graft Survival Humans Immunity, Cellular Immunity, Humoral Immunosuppressive Agents - therapeutic use Kidney Failure, Chronic - surgery Kidney Transplantation - standards Kidney Transplantation - statistics & numerical data Male Medication Adherence - statistics & numerical data Middle Aged Polyomavirus Infections - complications Recurrence Retrospective Studies Survival Rate T-Lymphocytes Thrombosis - complications Time Factors Tumor Virus Infections - complications |
title | Exploring the Complexity of Death-Censored Kidney Allograft Failure |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T14%3A44%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Exploring%20the%20Complexity%20of%20Death-Censored%20Kidney%20Allograft%20Failure&rft.jtitle=Journal%20of%20the%20American%20Society%20of%20Nephrology&rft.au=Mayrdorfer,%20Manuel&rft.date=2021-06-01&rft.volume=32&rft.issue=6&rft.spage=1513&rft.epage=1526&rft.pages=1513-1526&rft.issn=1046-6673&rft.eissn=1533-3450&rft_id=info:doi/10.1681/ASN.2020081215&rft_dat=%3Cpubmed_cross%3E33883251%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c435t-4dfb3f0cb88155a6e45634b4b52a68aabbdefc4e814e6b81443545a88d616d053%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/33883251&rfr_iscdi=true |